1. Home
  2. NRO vs PROC Comparison

NRO vs PROC Comparison

Compare NRO & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRO
  • PROC
  • Stock Information
  • Founded
  • NRO 2003
  • PROC 1976
  • Country
  • NRO United States
  • PROC Luxembourg
  • Employees
  • NRO N/A
  • PROC N/A
  • Industry
  • NRO Finance/Investors Services
  • PROC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRO Finance
  • PROC Health Care
  • Exchange
  • NRO Nasdaq
  • PROC Nasdaq
  • Market Cap
  • NRO 187.8M
  • PROC 203.1M
  • IPO Year
  • NRO N/A
  • PROC N/A
  • Fundamental
  • Price
  • NRO $3.75
  • PROC $0.69
  • Analyst Decision
  • NRO
  • PROC
  • Analyst Count
  • NRO 0
  • PROC 0
  • Target Price
  • NRO N/A
  • PROC N/A
  • AVG Volume (30 Days)
  • NRO 239.4K
  • PROC 23.9K
  • Earning Date
  • NRO 01-01-0001
  • PROC 11-26-2024
  • Dividend Yield
  • NRO 11.41%
  • PROC N/A
  • EPS Growth
  • NRO N/A
  • PROC N/A
  • EPS
  • NRO N/A
  • PROC 0.52
  • Revenue
  • NRO N/A
  • PROC $414,096,000.00
  • Revenue This Year
  • NRO N/A
  • PROC $5.54
  • Revenue Next Year
  • NRO N/A
  • PROC $8.54
  • P/E Ratio
  • NRO N/A
  • PROC $1.34
  • Revenue Growth
  • NRO N/A
  • PROC N/A
  • 52 Week Low
  • NRO $2.51
  • PROC $0.58
  • 52 Week High
  • NRO $3.45
  • PROC $4.95
  • Technical
  • Relative Strength Index (RSI)
  • NRO 35.09
  • PROC 14.88
  • Support Level
  • NRO $3.77
  • PROC $1.52
  • Resistance Level
  • NRO $3.98
  • PROC $1.76
  • Average True Range (ATR)
  • NRO 0.08
  • PROC 0.16
  • MACD
  • NRO -0.01
  • PROC -0.12
  • Stochastic Oscillator
  • NRO 3.70
  • PROC 7.79

About NRO Neuberger Berman Real Estate Securities Income Fund Inc.

NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. The fund invests in sectors, such as apartments, Data Centers, Infrastructure REITs, Manufactured Homes, Office, Regional Malls and others.

About PROC Procaps Group S.A.

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Share on Social Networks: